Publication Beamlines Strategic Pillar
Douglas ULLRICH (2024). Janela de saída de um acelerador linear para feixe de elétrons, para uso na produção de radioisótopos, sistemas e métodos. Patent Number: BR112019015503. Materials
William Diamond; Vinay NAGARKAL; Mark de JONG; Christopher REGIER; Linda Lin et al. (2024). APPARATUS FOR PRODUCING MOLYBDENUM-99 (99MO) FROM A PLURALITY OF MOLYBDENUM-100 (100MO) TARGETS BY A PHOTO-NUCLEAR REACTION ON THE 100MO TARGETS. Patent Number: BR112015029336B1. Materials
Томас ШПРЕТЕР ФОН КРЕДЕНШТАЙН; Сержит Бхимарао ДИКСИТ; Эрик ЭСКОБАР-КАБРЕРА; Пола Ирэн ЛАРИО; Дэвид Кай Юэнь ПУН et al. (2023). DEVELOPMENT OF STABLE HETERODIMERIC ANTIBODY WITH MUTATIONS IN Fc DOMAIN. Patent Number: RU2810540C2. Health
Folgueira Judit Anido; Johan Fransson; Jean Philippe Julien; Swetha Raman; Suarez Joan Seoane et al. (2025). Antibodies against lif and uses thereof. Patent Number: NZ755004B2. Agriculture
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.
(2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL320478A.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.